Skip to main content

Find Clinical Trials

Home
Conditions
Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus Influenzae Type b-Neisseria Meningitidis Vaccin

Clinical trial condition

Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus Influenzae Type b-Neisseria Meningitidis Vaccin

Explore clinical trials studying Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus Influenzae Type b-Neisseria Meningitidis Vaccin. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus Influenzae Type b-Neisseria Meningitidis Vaccin trial results

Completed

Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m

NCT00136604

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +22 more
Locations: GSK Investigational Site Bangkok, Thailand

GSK Investigational Site Khon Kaen, Thailand

GSK Investigational Site Songkhla, Thailand

View Trial Details

Completed

Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children

NCT00228917

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +22 more
Locations: GSK Investigational Site City of Muntinlupa, Philippines

GSK Investigational Site Bangkok, Thailand

View Trial Details